Ugggh! In an article on prices, the story gets around to profits.
And this:
The Atlantic Magazine gets a lot of drug advertising, so it is bought and paid for when it comes to addressing problems. Too bad. If drug company profits were near zero, and drug companies did not have "walking around money" the Atlantic might have to hire talent to stay publishing. Patents rot out out entire system.
Feel free to forward this by email to three of your friends.
“Hopes that the fundamentals of a free market economy and market competition will settle cancer drug prices at lower levels have not been fulfilled,” the doctors said in the paper released yesterday.Hopes cannot be fulfilled if the process is never even tried. Prosperity has at the root of the term the Latin "spero," to hope. In capitalism there is no hope for a free market. With usury and patents, we can hardly call it a free market. If you want to see profits whittled down to practically nothing, then open medicine to the free market, for the first time. If you want to see more better cheaper faster, deregulate medicine.
And this:
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?Well, it does not cost that at all, only in USA companies can charge that because of patents. The article at once cites the nonsense that a new drug costs a billion to develop, and then goes on to say the patent system spurs innovation, without any references to support that sheer nonsense.
Last month, Andrew Witty, the CEO of GlaxoSmithKline, called the often-cited $1 billion price tag for developing a new drug an "industry myth," based on unacceptably high research failure ratesNo it is not. A billion is allocated to a new drug to launder money away from taxes and to company perqs.
The Atlantic Magazine gets a lot of drug advertising, so it is bought and paid for when it comes to addressing problems. Too bad. If drug company profits were near zero, and drug companies did not have "walking around money" the Atlantic might have to hire talent to stay publishing. Patents rot out out entire system.
Feel free to forward this by email to three of your friends.
1 comments:
http://www.ipwatchdog.com/2013/11/05/private-election-companies-should-have-benefit-of-trade-secrets/id=46024/
Good grief: patents, trade secrets, vote counting and politics - what could go wrong here?! Typical lawyer thinking - footnotes galore, and maybe longer than the article itself.
Post a Comment